Notices. Notice
247 words·~1 min read·
/register/2002/06/27/02-16162A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4160-01-S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 02F-0142] Cyanotech Corp.; Withdrawal of Food Additive Petition AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration
(FDA)is announcing the withdrawal, without prejudice to a future filing, of a food additive petition (FAP 2A4732) proposing that the food additive regulations be amended to provide for the safe use of *Haematococcus* algae astaxanthin as a nutrient supplement. FOR FURTHER INFORMATION CONTACT: James C. Wallwork, Center for Food Safety and Applied Nutrition (HFS-265), Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD 20740, 202-418-3078. SUPPLEMENTARY INFORMATION: In a notice published in the **Federal Register** of April 11, 2002 (67 FR 17700), FDA announced that a food additive petition (FAP 2A4732) had been filed by Cyanotech Corp., c/o T. Todd Lorenz, 11034 West Ocean Air Dr., # 252, San Diego, CA 92130 (currently 73-4460 Queen Kaahumanu Hwy., # 102, Kailua-Kona, HI 96740). The petition proposed to amend the food additive regulations in Part 172 *Food Additives Permitted for Direct Addition to Food for Human Consumption* (21 CFR part 172) to provide for the safe use of *Haematococcus* algae astaxanthin as a nutrient supplement. Cyanotech Corp. has now withdrawn the petition without prejudice to a future filing (21 CFR 171.7(a)). Dated: June 3, 2002. Laura M. Tarantino, Deputy Director, Office of Food Additive Safety, Center for Food Safety and Applied Nutrition. [FR Doc. 02-16162 Filed 6-26-02; 8:45 am]
Connectionstraces to 1
Traces to 1 document
1 reference not yet in our index
- 21 CFR 172
Citation graph
cites case law
Cites 2Cited by 0 across 0 sources